CD8A and rheumatoid arthritis: This hypothesis is supported by the identification of somatic mutations in the circulating, cytotoxic CD8+ and CD4+ lymphocytes in RA, Felty’s syndrome, aplastic anemia, multiple sclerosis, chronic graft-versus-host-disease (cGVHD) and common variable immune deficiency patients (16–22).